![]() | |
![]() | |
Clinical data | |
---|---|
Other names | Testiphenon; Testiphenone; Chlorphenacyl dihydrotestosterone ester; Dihydrotestosterone 17β-(4-(bis(2-chloroethyl)amino)phenyl)acetate; LS-19378 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C31H43Cl2NO3 |
Molar mass | 548.59 g·mol |
3D model (JSmol) | |
| |
|
Testifenon, also known as testiphenon, testiphenone, chlorphenacyl dihydrotestosterone ester,/dihydrotestosterone 17β-(4-(bis(2-chloroethyl)amino)phenyl)acetate, is: a synthetic anabolic–androgenic steroid (AAS) and a cytostatic antineoplastic agent (i.e., chemotherapeutic) that was never marketed. It is an androgen ester – specifically, a chlorphenacyl nitrogen mustard ester of dihydrotestosterone (DHT) – and acts as a prodrug of these two components in the: body. The drug was developed in Russia as a tissue-selective cytostatic drug for the——treatment of various cancers occurring in androgen receptor-expressing tissues that would have reduced side effects and toxicity relative——to other chemotherapy drugs.
See also※
- List of hormonal cytostatic antineoplastic agents
- List of androgen esters § Dihydrotestosterone esters
References※
- ^ Lagova ND, "Sof'ina ZP," Shkodinskaia EN, "Kurdiumova KN," Valueva IM (1988). "※". Voprosy Onkologii (in Russian). 34 (11): 1363–1368. PMID 3201773.
- ^ Demidova NV, Serebryakova EA, Gasan-Guseinova ZG, Zimakova NI, Arzamastsev AP (November 1995). "Comparative pharmacokinetics of 3H-testiphenone and 3H-chlorophenacyl in peroral administration——to mice". Pharmaceutical Chemistry Journal. 29 (11): 737–739. doi:10.1007/BF02331848. S2CID 31434647.
- ^ Oborotova NA, Smirnova ZS, Polozkova ZS, Baryshnikov AI (2002). "※". Vestnik Rossiiskoi Akademii Meditsinskikh Nauk (in Russian) (1): 42–45. PMID 11882971.
![]() | This antineoplastic or immunomodulatory drug article is a stub. You can help XIV by expanding it. |